1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsDrug Use and Addiction Research Programs (SBIR/STTR) is sponsored by National Institute on Drug Abuse (NIDA), National Institutes of Health (NIH), Department of Health and Human Services (HHS). This opportunity supports mission-aligned projects and measurable outcomes.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
A **. gov** website belongs to an official government organization in the United States. NIH Websites Are Changing Get the Latest Updates and FAQs.
* Psychedelic and Dissociative Drugs * Psilocybin (Magic Mushrooms)") * Stigma and Discrimination * Tobacco/Nicotine and Vaping * Resources for Parents and Educators * Words Matter: Preferred Language * Research Training & Career Development * NIDA Research Programs & Activities * NIH Policies & Guidance * Research Data, Measures, & Resources * Resources for Grants & Contracts * NIDA Drug Supply Program * Clinical Trials Stewardship NIDAMED: Clinical Resources * Health Professions Education * Marijuana and Other Drugs * Opioid Crisis and Pain Management * Screening Tools & Prevention * Screening and Assessment Tools Chart * Words Matter - Terms to Use and Avoid When Talking About Addiction * Small Business Innovation Research (SBIR) and Technology Transfer (STTR) Programs and Technology Transfer (STTR) Programs") * Grant Application Forms * Grants & Contract Application Process * NIDA Notice of Special Interest (NOSI) * NIH Office of Communications * Clinical Trials Network * Frequently Asked Questions [](https://nida.
nih. gov/) # National Institute on Drug Abuse Supporting scientific research on drug use and addiction See research on substance use ### NIH research clears way for study of experimental treatment for opioid use disorder IND in effect for human safety study of mitragynine, a kratom isolate.
### NIDA research is advancing progress against HIV In Dr. Nora Volkow’s latest blog, she describes major NIDA initiatives at the intersection of HIV and addiction, aimed... Browse our new page with key facts on drugs. Learn about health effects, risks, and treatment options.
## NIDA Points of Interest Advancing the science on drug use and addiction Nora D. Volkow, M. D.
, became Director of NIDA in May 2003. Research grants, contracts, and supplements related to drug use and addiction. ### NIDAMED: Clinical Resources Substance use screening tools, guidelines, and other resources.
Programs to support research training from high school through tenure. ### NIDA Research Programs & Activities Learn about NIDA-supported research and cross-agency research activities on drug use and addiction. ## Medications for Opioid Use Disorder Medications for opioid use disorder are safe, effective, and save lives.
This NIDA-produced video takes a closer look at these medications and how they work.
## Explore Topics in Substance Use and Addiction Science * Stigma and Discrimination * Psychedelic and Dissociative Drugs Explore All Research Topics Explore All Research Topics * HIV Research Program (HRP) * Clinical Trials Network * ABCD Study® - Adolescent Brain ## Upcoming Meetings/Events ### National Advisory Council on Drug Abuse: Open Session – September 2026 Tuesday, September 8, 2026 1:00pm to 4:30pm |Neuroscience Center, 6001 Executive Blvd ## Looking for Treatment?
Use the SAMHSA Treatment Locator or call 1-800-662-HELP (4357). ## Participate in a Clinical Trial Learn more about clinical research and how to participate in a NIDA-funded or NIDA-conducted clinical trial. * NIDAMED: Clinical Resources * Freedom of Information Act (FOIA)") * Frequently Asked Questions * NIDA Research Studies in Baltimore * Intramural Research Program [](https://nida.
nih. gov/about-nida/contact-us)[](https://twitter. com/NIDAnews)[](https://www.
facebook. com/NIDANIH)[](https://www. linkedin.
com/company/the-national-institute-on-drug-abuse-nida)[](https://www. youtube. com/user/NIDANIH) * U.S. Department of Health and Human Services * National Institutes of Health * National Institute on Drug Abuse NIH...
Turning Discovery Into Health ®
According to the current listing, eligibility includes: Small business concerns (SBCs) are eligible to participate in SBIR/STTR programs. Confirm the full requirements in the official notice before applying.
The current listing shows normally may not exceed $306,872 for Phase I, and $2,045,816 for Phase II, unless proposal fall under one of the approved topics. Verify award ceilings, matching requirements, and allowable costs in the official notice.
Drug Use and Addiction Research Programs (SBIR/STTR) is funded by National Institute on Drug Abuse (NIDA), National Institutes of Health (NIH), Department of Health and Human Services (HHS). Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Past winners and funding trends for this program
The HEAL Initiative's Studies to Enable Analgesic Discovery award (RFA-NS-25-023) puts federal money exactly where private capital won't go — the assay-building, screening, and hit-characterization stage of non-opioid pain therapeutics. It's a phased R61/R33, up to $350,000 in direct costs per year, with the next application deadline September 17, 2026. Here is how the two-phase structure works, who's eligible, and how to build a proposal that survives the R61-to-R33 milestone gate.
Read articleThe Health and Extreme Weather highlighted topic went live September 1, 2026 with eleven awarding institutes and expires May 1, 2028. There is no set-aside, no separate deadline, and no review criteria — which makes the institute-by-institute language the only real signal, and it is not uniform.
Read articleThe NOURISH Autoimmunity Digital Health Challenge runs three phases to August 2028: 10 winners at $20,000, then 5 at $30,000, then 3 at $100,000. It is a prize competition, not a grant — no indirect costs, no cost reimbursement, and a rule that quietly disqualifies the obvious applicant.
Read article